Evidence map›Paper›PMID 39545410›Full record

ArticleThe Journal of clinical investigation2024

Defects in meiosis I contribute to the genesis of androgenetic hydatidiform moles.

Maryam Rezaei, Manqi Liang, Zeynep Yalcin, Jacinta H Martin, Parinaz Kazemi, Eric Bareke, Zhao-Jia Ge, Majid Fardaei, Claudio Benadiva, Reda Hemida and 22 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Maryam RezaeiDepartment of Human Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
Manqi LiangDepartment of Human Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
Zeynep YalcinDepartment of Human Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
Jacinta H MartinDepartment of Human Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
Parinaz KazemiDepartment of Biology, McGill University, Montreal, Quebec, Canada.
Eric BarekeDepartment of Human Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
Zhao-Jia GeDepartment of Human Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
Majid FardaeiDepartment of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.
Claudio BenadivaCenter for Advanced Reproductive Services, Farmington, Connecticut, USA.
Reda HemidaDepartment of Obstetrics and Gynecology, Mansoura University, Mansoura, Egypt.
Adnan HassanDepartment of Obstetrics and Gynecology, Jordan Hospital, Amman, Jordan.
Geoffrey J MaherDepartment of Surgery and Cancer, Imperial College London, London, United Kingdom.
Ebtesam AbdallaDepartment of Human Genetics, Medical Research Institute, Alexandria University, Alexandria, Egypt.
William BuckettDepartment of Obstetrics and Gynecology, McGill University Health Centre, Montreal, Quebec, Canada.
Pierre-Adrien BolzeUniversité Lyon 1, Service de Chirurgie Gynécologique et Ontologique, Obstétrique, Centre Français de Référence des Maladies Trophoblastiques, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre Bénite, France.
Iqbaljit SandhuDepartment of Human Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
Onur DumanSecurity Research Center, Concordia University, Montreal, Quebec, Canada.
Suraksha AgrawalDepartment of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
JianHua QianDepartment of Gynecology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jalal Vallian BroojeniDepartment of Human Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
Lavi BhatiDepartment of Human Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
Pierre MironCentre d'Aide Médicale à la Procréation Fertilys, Laval, Quebec, Canada.
Fabienne AlliasDepartment of Pathology, Hospices Civils de Lyon, Centre, Hospitalier Lyon Sud, Pierre-Bénite, France.
Amal SelimDepartment of Medical Biochemistry and Molecular Biology, Mansoura University, Mansoura, Egypt.
Rosemary A FisherDepartment of Surgery and Cancer, Imperial College London, London, United Kingdom.
Michael J SecklDepartment of Surgery and Cancer, Imperial College London, London, United Kingdom.
Philippe SauthierDepartment of Obstetrics and Gynecology, Gynecologic Oncology Division, Centre Hospitalier de l'Université de Montréal, Réseau des Maladies Trophoblastiques du Québec, Montreal, Quebec, Canada.
Isabelle TouitouDepartment of Genetics CHU of Montpellier, University of Montpellier, INSERM, Montpellier, France.
Seang Lin TanDepartment of Obstetrics and Gynecology, McGill University Health Centre, Montreal, Quebec, Canada.
Jacek MajewskiDepartment of Human Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
Teruko TaketoDepartment of Obstetrics and Gynecology, McGill University Health Centre, Montreal, Quebec, Canada.
Rima SlimDepartment of Human Genetics, McGill University Health Centre, Montreal, Quebec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To identify novel genes responsible for recurrent hydatidiform moles (HMs), we performed exome sequencing on 75 unrelated patients who were negative for mutations in the known genes. We identified biallelic deleterious variants in 6 genes, FOXL2, MAJIN, KASH5, SYCP2, MEIOB, and HFM1, in patients with androgenetic HMs, including a familial case of 3 affected members. Five of these genes are essential for meiosis I, and their deficiencies lead to premature ovarian insufficiency. Advanced maternal age is the strongest risk factor for sporadic androgenetic HM, which affects 1 in every 600 pregnancies. We studied Hfm1-/- female mice and found that these mice lost all their oocytes before puberty but retained some at younger ages. Oocytes from Hfm1-/- mice initiated meiotic maturation and extruded the first polar bodies in culture; however, their meiotic spindles were often positioned parallel, instead of perpendicular, to the ooplasmic membrane at telophase I, and some oocytes extruded the entire spindle with all the chromosomes into the polar bodies at metaphase II, a mechanism we previously reported in Mei1-/- oocytes. The occurrence of a common mechanism in two mouse models argues in favor of its plausibility at the origin of androgenetic HM formation in humans.

Indexed as

Hydatidiform MoleMeiosisMice, KnockoutAdultAnimalsFemaleHumansMiceOocytesPregnancyProteinsUterine NeoplasmsKHDC3L protein, humanProteinsFertilityGeneticsMonogenic diseasesReproductive biology

Identifiers

PMID39545410
PMCPMC11563684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.